An interventional study of Train-Your-Brain (TYB) Stroke Recovery Programme in Stroke, sponsored by National University of Singapore. Recruiting at 1 site in Singapore. Open to participants aged 21 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-08-26.
Sponsored by National University of Singapore · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 104 studies in Stroke with a site in Singapore — 16 open to participants now, 21 under way, 1 of them phase 3. Stroke · Singapore.
Among the 104 studies in Stroke with a site in Singapore, this one is the 33rd largest by planned enrollment of the 86 interventional ones that give a count, is one of 7 that started in 2025, is one of 58 with no phase, reaches primary completion later than 6 of the 20 other live ones, and was the 95th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →16 of the 104 studies in Stroke with a site in Singapore are open now. Recruiting first, the newest first:
The Hong Kong Polytechnic University · Sites in Singapore, Hong Kong
Ages 21–79 · Healthy volunteers
Tan Tock Seng Hospital · Sites in Singapore
Ages 21–80
Mah Shi Min · Sites in Singapore
Ages 21–99
Tan Tock Seng Hospital · Sites in Singapore
Ages 50+
Nanyang Technological University · Sites in Singapore
Ages 21–99
A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 21 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
104 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 7 · Phase 3 15 · Phase 4 7
First in 1998; this study’s year is marked. 7 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 51 across the 86 interventional studies, 300 across the 17 observational. Of the 79 that completed or were terminated, 16 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
22 of 104 have an industry lead sponsor. The 10 most frequent:
National University of Singapore is the lead sponsor of 212 studies on the registry; 50 are open to participants now.
National University of Singapore has 6 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
6 of the studies in Stroke with a site in Singapore that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06999876National University Health System, SingaporeThe Effect of Combined Transcranial Pulse Current Stimulation (tPCS) and Transcutaneous Electrical Nerve Stimulation (TENS) on Lower Limb Motor Function in Subacute to Chronic Stroke Patients With Hemiplegia (COMPENSATOR-Stroke) | 2026-11-30 |
| NCT06704997Tan Tock Seng HospitalMachine Learning to Predict Factors Affecting Rehabilitation Length of Stay and Healthcare Costs for Neurological Rehabilitation | 2026-12-31 |
| NCT06409351Singapore General HospitalMulti-modal Training Program to Promote Physical Activity After Stroke | 2026-12-31 |
| NCT06073106Tan Tock Seng HospitalTargeting Osteosarcopaenia and Multimorbidity for Frailty Prevention | 2027-01 |
| NCT07122752Tan Tock Seng HospitalFeasibility and Outcomes of 3D-printed External Cranial Orthosis After Craniectomy | 2027-08-29 |
Add all 6 to your calendar (.ics) → With an account.
Among the 104 studies in Stroke with a site in Singapore, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study addresses the growing burden of stroke in Singapore and highlights the lack of rehabilitation services for return to work after stroke. Despite functional physical recovery, many stroke survivors experience persistent impairments that hinder return-to-work. To bridge this gap, the study will implement a community-based brain health programme targeting cognitive and vocational outcomes in stroke survivors. Caregivers will also be included due to their critical support role. The study will assess the intervention's feasibility, acceptability, and its impact on cognitive function, return-to-work, neuroplasticity, psychosocial health, fatigue, and self-care.
Stroke is the fourth leading cause of death and the leading cause of adult disability in Singapore. Statistics indicate a concerning rise in young stroke cases. The burden of stroke care is expected to increase exponentially, posing significant challenges to the healthcare system and society. Cognitive impairment after stroke has been documented in up to one-third of stroke survivors. These impairments may be subtle but persistent and progressive even after the stroke survivor appears to have made functional recovery in other areas. Existing services in Singapore for stroke survivors typically target physical and daily functioning outcomes with little focus on cognitive functioning. Moreover, there is a lack of services for stroke survivors who face difficulties in returning to work due to cognitive impairment even when they have achieved optimal physical recovery. An important assessment of a rehabilitation intervention programme is in examining whether it drives positive neuroplasticity, which leads to improved cognitive and functional outcomes. There is presently a dearth of literature in brain mechanisms underlying the impact of cognitive rehabilitation.
A community-based brain health intervention, the Train-Your-Brain Stroke Recovery Programme, will be delivered by registered clinical neuropsychologists. Designed to enhance cognitive function and return-to-work outcomes in stroke survivors with mild cognitive impairment, the intervention will be evaluated using a mixed-methods randomized controlled trial. Stroke survivors will be randomized 1:1 into either the intervention or control arm. Caregivers, given their critical support role, will also be recruited to participate in the study. Outcome measures include feasibility of intervention, acceptability of intervention, cognitive function, return-to-work outcomes, changes in biomarkers, neuroimaging findings, psychosocial health, fatigue, and self-care. Outcome measures will be conducted pre-intervention, post-intervention, and 6-month follow-up.
Inclusion Criteria (for stroke survivors):
Inclusion Criteria (for caregivers):
Exclusion Criteria (for stroke survivors):
Exclusion Criteria (for caregivers):
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will undergo the group-based Train-Your-Brain Stroke Recovery Programme.
Other: Train-Your-Brain (TYB) Stroke Recovery Programme
Participants will undergo treatment-as-usual from their respective treatment providers.
The intervention involves a structured brain health programme delivered by clinical neuropsychologists in three phases: an initial needs assessment, a multi-session intervention, and follow-up support. Participants will receive assessments, attend group sessions covering topics such as lifestyle, mood, cognition, and return-to-work strategies, and be supported with workbooks and referrals to community services. The programme combines in-person and online formats.
Number of eligible/ineligible participants
Percentage of eligible/ineligible participants and reasons for ineligibility
Time frame: Through study completion, an average of 6 months
Recruitment and attrition rates
Percentage of recruited participants and drop-outs
Time frame: Through study completion, an average of 6 months
VasCog Screen Test
Test is comprised of a short-Montreal Cognitive Assessment (total score out of 12) and modified Symbol Digit Modalities Test (score calculated based on correct responses)
Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up
Vascular Dementia Battery
Participants will meet criteria for Mild Cognitive Impairment if there is 1 or more domain(s) with failure in at least 50% of tasks in domain
Time frame: Baseline (pre-intervention)
National Institute of Neurological Disorders and Stroke - Canadian Stroke Network (NINDS-CSN) Stroke Protocol
A test battery comprised of cognitive tests that are measured against their respective normative scores
Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up
Return-to-work Questionnaire (National Institute of Neurological Disorders and Stroke - Common Data Elements)
Survey questions of participants' work status before and after stroke with check-box responses
Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up
Intervention fidelity
Intervention Fidelity Checklist (eNACT Group Facilitation Competency Checklist) * "Observed - Done well" and "Observed - Done adequately" is equivalent to a score of 2; "Observed - Not done well" is equivalent to a score of 1; "Not observed - despite opportunity" is equivalent to a score of 0 * An overall score of 2 reflects adequate competence in group facilitation
Time frame: During the intervention and immediately after the intervention
Qualitative interviews
Semi-structured interviews will be conducted with stroke survivors and family members to obtain feedback about their experiences of the intervention
Time frame: Immediately after the intervention
Participants' acceptability of the intervention
Feedback forms provided after each intervention session rated on a 5-point response scale from Strongly Disagree to Strongly Agree
Time frame: During the intervention
Patient-Reported Outcomes Measurement Information System (PROMIS) - 10
5-point response scale from Excellent (5) to Poor (1)
Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up
EuroQol 5-Dimension 5-Level (EQ-5D-5L)
Survey questions of participants' Mobility, Self-care, Usual activities, Pain/discomfort, and Anxiety/depression with check-box responses across five levels of severity, ranging from no problems to extreme problems.
Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up
Fatigue Assessment Scale
5-point response scale from Always (5) to Never (1)
Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up
Depression, Anxiety, Stress Scale
3-point response scale from Did not apply to me at all (0) to Applied to me very much, or most of the time (3)
Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up
Zarit Burden Interview
4-point response scale from Nearly Always (4) to Never (0)
Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up
Voils Domains Of Subjective Extent of Nonadherence
Survey questions on participants' extent and reasons for nonadherence with check-box responses (None of the time, A little of the time, Some of the time, Most of the time, Every time)
Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up
Blood Pressure Measurement
Measurement of participants' blood pressure reading
Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up
Blood-Derived Neurotrophic Factor
Blood biomarker derived from participants' blood samples
Time frame: Immediately after the intervention, 6-months follow-up
Functional near-infrared spectroscopy measurement
Measurement of oxyhaemoglobin (HbO2), deoxyheemoglobin (HbR), and regional oxygen saturation (rSO2) while participants undergo various cognitive tests (e.g. N-back Task, verbal fluency test, Stroop Task)
Time frame: Immediately after the intervention, 6-months follow-up
Cost Effectiveness Analysis Questionnaire
Time frame: Immediately after the intervention, 6-months follow-up
Plan to share: Yes — All collected and deidentified IPD
No publications or documents are linked to this record.
Started Aug 2025 (actual). Primary completion is estimated for Aug 2026, 11 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 11 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National University of Singapore →